Search Within

Joachim Yahalom

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (16)
  3. Research Letter (2)
  4. Book Section (1)
Groups
  1. Department of Pathology and Laboratory Medicine (38)
  2. Radiation Oncology, Department of (38)
  3. Survivorship Research (38)
  4. Department of Medicine (34)
  5. Hematologic Malignancies, Division of (32)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Ahmet Dogan (29)
  2. Andrew Zelenetz (22)
  3. Ariela Noy (20)
  4. Alison Moskowitz (19)
  5. Paul Hamlin (19)
  6. Steven Horwitz (19)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (9)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (4)

More Years

Publications
  1. Blood (10)
  2. Hematological Oncology (7)
  3. Blood Advances (3)
  4. Journal of Clinical Oncology (3)
  5. Blood Cancer Journal (2)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Wiley Blackwell (7)
  3. American Society of Clinical Oncology (3)
  4. Nature Publishing Group (3)
  5. Elsevier Inc. (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular features are associated with disease stage in diffuse large B-cell lymphoma and reveal heterogeneity in patient outcomes
    Meeting Abstract

    Uppal, M.; Gurumurthi, A.; Hamlin, P. A.; Falchi, L.; Horwitz, S.; Kumar, A.; Noy, A.; Lue, J. K.; Torka, P.; Arcila, M. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Radiation therapy for Burkitt lymphoma: Multi-decade insights from a single center
    Meeting Abstract

    Tward, A.; Patel, R. R.; Isgor, I.; Galera, P.; Lopez, K.; Fregonese, B.; Moore, Z.; Wolden, S.; Yahalom, J.; Imber, B. S.
    Blood (2024)

    Fulltext@MSK | Save
  • Associations between genetic alterations in follicular lymphoma and radiosensitivity
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Chan, A.; Lee, J.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H. G.; Ma, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patient selection using genetic alterations associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Lee, J.; Fregonese, B.; Tringale, K.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save